Dyadic Announces Third Quarter 2023 Financial Results and Highlights Recent Company Progress
November 08, 2023 16:00 ET
|
Dyadic International, Inc.
Received an upfront payment of $0.6 million in October for product development and licensing of our Dapibus™ platform for animal-free dairy enzyme productsDYAI-100 Phase 1 clinical trial top-line...
Global Digital Biomanufacturing Market Analysis Report 2023-2027 - Partnerships Driving Adoption of Modern Manufacturing Technologies
October 16, 2023 06:58 ET
|
Research and Markets
Dublin, Oct. 16, 2023 (GLOBE NEWSWIRE) -- The "Digital Biomanufacturing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027 Segmented By Technology, By Application, By...
China's Position in the Global Biopharmaceutical Manufacturing Industry: 2023 Insights - Navigating the Evolving Landscape
October 13, 2023 04:03 ET
|
Research and Markets
Dublin, Oct. 13, 2023 (GLOBE NEWSWIRE) -- The "China's Position in Global Manufacturing: A Comparison of China's Emerging Position vs Established Regions' Manufacturing Capacity and Production"...
California Biomanufacturing Center Awarded ARPA Grant to Train Biotechnology Workforce
October 10, 2023 11:15 ET
|
California Biomanufacturing Center
The California Biomanufacturing Center said the City of Vacaville awarded it a two-year, $750,000 grant to retrain displaced workers.
Dyadic Appoints Doug Pace to Its Executive Leadership Team
October 09, 2023 08:30 ET
|
Dyadic International, Inc.
JUPITER, Fla., Oct. 09, 2023 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company focused on building...
A Greener Tomorrow: White Biotechnology Market's Rise, Trends, and Projections to 2034
September 25, 2023 05:58 ET
|
Research and Markets
Dublin, Sept. 25, 2023 (GLOBE NEWSWIRE) -- The "The Global Market for White Biotechnology 2024-2034" report has been added to ResearchAndMarkets.com's offering. White biotechnology utilizes...
Dyadic to Present at BioProcess International
September 12, 2023 16:30 ET
|
Dyadic International, Inc.
JUPITER, Fla., Sept. 12, 2023 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company focused on building innovative microbial...
Global Cell and Gene Therapy CDMO Market, Focused on AAV, Set to Surge with 24.61% CAGR
August 30, 2023 09:33 ET
|
Research and Markets
Dublin, Aug. 30, 2023 (GLOBE NEWSWIRE) -- The "Cell and Gene Therapy Biomanufacturing CDMO Market - Focused on AAV - A Global and Regional Analysis: Focus on Phase of Development, Workflow,...
Global Biomanufacturing Viral Detection Market Set to Surpass $1.15 Billion by 2032, Fueled by Growing Biopharmaceutical Utilization
August 15, 2023 07:28 ET
|
Research and Markets
Dublin, Aug. 15, 2023 (GLOBE NEWSWIRE) -- The "Biomanufacturing Viral Detection and Quantification Market - A Global and Regional Analysis: Focus on Offering Type, Technology, Application, End User,...
Dyadic Announces Second Quarter 2023 Financial Results and Highlights Recent Company Progress
August 09, 2023 16:00 ET
|
Dyadic International, Inc.
Positive Interim Phase 1 clinical trial safety results for C1 platform for manufacturing human vaccines Two MoU’s with Fondazione Biotecnopolo di Siena in Italy and Essential Drugs Company Limited...